Cited 0 times in
Adjuvant trastuzumab plus pertuzumab (TP) versus trastuzumab (T) alone in patients achieving pathologic complete response after chemotherapy with 쎼
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.